Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14437968 | 0.74 | ALDH1A1 (0.31) | ALDH1A1HSD17B10 | |
| SCHEMBL21477589 | 0.69 | ALDH1A1 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL12940669 | 0.69 | ALDH1A1 (0.36) | ALDH1A1HSD17B10 | |
| SCHEMBL19756503 | 0.69 | DYRK1A (0.33) | — | |
| SCHEMBL17132581 | 0.69 | ALDH1A1 (0.41) | ALDH1A1HSD17B10 | |
| SCHEMBL24174572 | 0.67 | NOS3 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL18237421 | 0.65 | ADORA3 (0.31) | — | |
| SCHEMBL13557977 | 0.65 | ALDH1A1 (0.41) | ALDH1A1HSD17B10 | |
| SCHEMBL17265832 | 0.65 | ALDH1A1 (0.37) | ALDH1A1HSD17B10 | |
| SCHEMBL12890883 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO INC (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | ALDH1A1 2151/4885HSD17B10 3435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.